Trial · NCT02070978
Results by group420
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 420
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With at Least One Serious Adverse Event (SAE) During the Treatment Period | Placebo/Atacicept 150 mg | 13 | Participants | ||
| Number of Participants With at Least One Serious Adverse Event (SAE) During the Treatment Period | Atacicept 75 mg | 10 | Participants | ||
| Number of Participants With at Least One Serious Adverse Event (SAE) During the Treatment Period | Atacicept 150 mg | 9 | Participants | ||
| Number of Participants Who Prematurely Discontinued the Treatment Due to Adverse Event (AE) | Placebo/Atacicept 150 mg | 9 | Participants | ||
| Number of Participants Who Prematurely Discontinued the Treatment Due to Adverse Event (AE) | Atacicept 75 mg | 4 | Participants | ||
| Number of Participants Who Prematurely Discontinued the Treatment Due to Adverse Event (AE) | Atacicept 150 mg | 5 | Participants | ||
| Change From Baseline in Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index Organ Damage Scores | Placebo/Atacicept 150 mg | Baseline; Day 1 (Core Study) | 1 | Standard Deviation 1.0 | Units on a scale |
| Change From Baseline in Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index Organ Damage Scores | Atacicept 75 mg | Baseline; Day 1 (Core Study) | 1 | Standard Deviation 1.2 | Units on a scale |
| Change From Baseline in Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index Organ Damage Scores | Atacicept 150 mg | Baseline; Day 1 (Core Study) | 0 | Standard Deviation 0.8 | Units on a scale |
| Change From Baseline in Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index Organ Damage Scores | Placebo/Atacicept 150 mg | Change at LTE Day 1 | 0 | Standard Deviation 0.0 | Units on a scale |
| Change From Baseline in Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index Organ Damage Scores | Atacicept 75 mg | Change at LTE Day 1 | 0 | Standard Deviation 0.1 | Units on a scale |
| Change From Baseline in Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index Organ Damage Scores | Atacicept 150 mg | Change at LTE Day 1 | 0 | Standard Deviation 0.0 | Units on a scale |
| Change From Baseline in Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index Organ Damage Scores | Placebo/Atacicept 150 mg | Change at LTE Week 24 | 0 | Standard Deviation 0.1 | Units on a scale |
| Change From Baseline in Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index Organ Damage Scores | Atacicept 75 mg | Change at LTE Week 24 | 0 | Standard Deviation 0.1 | Units on a scale |
| Change From Baseline in Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index Organ Damage Scores | Atacicept 150 mg | Change at LTE Week 24 | 0 | Standard Deviation 0.2 | Units on a scale |
| Change From Baseline in Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index Organ Damage Scores | Placebo/Atacicept 150 mg | Change at LTE Week 48 | 0 | Standard Deviation 0.2 | Units on a scale |
| Change From Baseline in Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index Organ Damage Scores | Atacicept 75 mg | Change at LTE Week 48 | 0 | Standard Deviation 0.2 | Units on a scale |
| Change From Baseline in Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index Organ Damage Scores | Atacicept 150 mg | Change at LTE Week 48 | 0 | Standard Deviation 0.3 | Units on a scale |
| Change From Baseline in Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index Organ Damage Scores | Placebo/Atacicept 150 mg | Change at LTE Week 72 | 0 | Standard Deviation 0.3 | Units on a scale |
| Change From Baseline in Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index Organ Damage Scores | Atacicept 75 mg | Change at LTE Week 72 | 0 | Standard Deviation 0.3 | Units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02070978/results